特种药品市场基础(关键地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00021699
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Specialty Pharmaceuticals Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场介绍 有助于治疗市场上没有任何治疗干预的特定遗传病症的药物分子被认为是特种药物。特种药物是更有针对性的药物,与传统药物联合使用时毒性较小。特种药品包括生物药品、血液制品和复杂分子。成本高的药品也属于特种药品。 市场动态 由于新制药行业的快速发展、药房之间的重大并购以及药品福利管理 (PBM) 和医疗保健计划的改进,特种药品市场正在不断发展。然而,特种药品的高成本将阻碍其增长。此外,特种药品的高购买力和报销预计将为全球特种药品市场提供机会。 市场范围 “2031年特种药品市场分析”是对医疗保健行业的专业和深入研究,特别关注全球市场趋势分析。该报告旨在提供特种药品市场的概述,并按类型和最终用户进行详细的市场细分。预计特种药品市场在预测期内将出现高速增长。该报告提供了特种药品市场领先企业的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分 特种药品市场根据给药途径、治疗领域和分销渠道进行细分。根据给药途径,市场分为口服、肠胃外、透皮给药。根据治疗领域,市场分为肿瘤学、炎症性疾病、多发性硬化症、生长激素和其他疾病。根据分销渠道,市场分为医院、零售药房、专科药房、邮购。 该报告提供了行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的特种药品市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲和中美洲。每个地区的特种药品市场随后按各自的国家和细分市场进行细分。该报告涵盖了对全球18个国家以及该地区当前趋势和机遇的分析和预测。该报告从需求和供应方面分析了影响特种药品市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估影响北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲的政治、经济、社会和技术因素后,对这些地区的特种药品市场进行了评估。 市场参与者 该报告涵盖了特种药品市场有机和无机增长战略的主要发展。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长策略包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对特种药品需求的不断增长,特种药品市场的市场参与者预计将在未来拥有利润丰厚的增长机会。下面提到的是从事特种药品市场的几家公司的名单。该报告还包括特种药品市场主要参与者的概况及其 SWOT 分析和市场策略。此外,该报告还重点关注领先的行业参与者,提供公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。
    • 辉瑞公司 • 安进公司 • 阿斯利康• 梯瓦制药工业有限公司 • 大冢美国制药公司 •  rEVO Biologics, Inc. • 艾伯维公司 • 吉利德• 杨森全球服务有限责任公司 • Celgene
Insight 合作伙伴的专门研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Pfizer Inc.
2. Amgen Inc.
3. AstraZeneca
4. Teva Pharmaceutical Industries Ltd.
5. Otsuka America Pharmaceutical, Inc.
6. rEVO Biologics, Inc.
7. AbbVie Inc.
8. Gilead
9. Janssen Global Services, LLC
10. Celgene
11. Ginger.io.
12. Lonza
13. ObsEva
14. Zealand Pharma
15. Polyphor
16. Aclaris Therapeutics
17. Allergan
18. Supernus Pharma
19. Taiho Pharmaceutical
20. AMAG Pharmaceuticals, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..